Plain-English translation of NCT06848647 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying how treating obstructive sleep apnea (a common sleep disorder where breathing stops and starts during sleep) with a CPAP machine affects your blood sugar and metabolic health. Researchers will follow 600 patients over 18 months, collecting detailed information about how well the CPAP treatment works for each person and how it affects blood sugar control. The goal is to create a personalized treatment approach that works better for different patients.
Many people with sleep apnea also have diabetes or prediabetes, and current treatment doesn't always account for individual differences like how much sleep someone gets or how long they've had diabetes. This trial exists to answer important unanswered questions: Does using the CPAP machine more consistently improve blood sugar? Should doctors address both short sleep and sleep apnea together? And does long-standing diabetes make the treatment less effective? Understanding these answers could help doctors tailor treatment to work better for each person.
You likely qualify if…
You likely don't qualify if…
You would use a CPAP machine as your regular sleep apnea treatment while researchers track your progress over 18 months. They will collect detailed information about how often you use the machine, how well it's working, your sleep patterns, and various blood and health measurements related to blood sugar control. The study uses existing clinic visits and data collection, so you won't need to come in extra times beyond your normal sleep apnea care.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Sweden